Crowdonomics
All companies
Assured Med Supply (AMS.AI) logo

Assured Med Supply (AMS.AI)

Operating

Assured Med Supply LLC

Healthcare · Founded 2020

AI co-pilot that could transform the $1.3 trillion medical distribution market

Post-money valuation ⓘ
$10.3M
As of Apr 2025 · from Reg CF Offering (2024) · pre-money + amount raised, not a traded price
Total raised
$1,250,750
Across 1 round since 2024

Financials

FY2022–FY2025 · from SEC filings · hover any figure for its source
$3.2M
$344K
2022
$41K
−$86K
2023
$0
−$87K
2024
$0
−$308K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 reviewed
FY2023 reviewed
FY2024 unaudited
FY2025 unaudited
Income statement
Revenue
$3,174,276
$41,307
$0
$0
Cost of goods sold
$2,538,884
$36,780
$0
$0
Gross margin
20%
11%
—
—
Net income
$343,909
-$86,032
-$86,548
-$308,142
Taxes paid
$10,485
$4,487
$800
$800
Balance sheet
Cash
$56,707
$15,013
$52,686
$742,780
Accounts receivable
$31,458
$0
$0
$0
Total assets
$141,125
$16,454
$52,686
$742,780
Short-term debt
$14,858
$1,048
$29,855
$28,111
Long-term debt
$0
$0
$0
$0
Total liabilities
$14,858
$1,048
$29,855
$28,111
Other
Headcount
—
5
—
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$9.0M
pre-money
Reg CF · Common · Aug 2024

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Raised $1.3M / $1.2MInvestors 365Post-money $10.3M

Team

4 people
Rostislav Malkin
CEO
Roy Malkin
CEO
Gary Lipsky
COO
Don Oparah
Manager (Director)

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 1 of 2 annual reports (FY2024–FY2025)

Missing: 2024

365 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 15, 20260002033449-26-000001
    EDGAR
  • Form C/AOct 2, 20240001670254-24-000977
    EDGAR
  • Form CAug 16, 20240001670254-24-000851
    EDGAR
Source: ManualCIK 0002033449

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.